Vanguard Group’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $34.2M | Buy |
|
|||||
|
2025
Q2 | $16.1M | Buy |
|
|||||
|
2025
Q1 | $11.5M | Buy |
|
|||||
|
2024
Q4 | $21.4M | Buy |
|
|||||
|
2024
Q3 | $28M | Buy |
|
|||||
|
2024
Q2 | $15.7M | Buy |
|
|||||
|
2024
Q1 | $14.4M | Buy |
|
|||||
|
2023
Q4 | $14.2M | Sell |
|
|||||
|
2023
Q3 | $11.1M | Sell |
|
|||||
|
2023
Q2 | $19.5M | Buy |
|
|||||
|
2023
Q1 | $15.3M | Buy |
|
|||||
|
2022
Q4 | $11.5M | Buy |
|
|||||
|
2022
Q3 | $3.65M | Buy |
|
|||||
|
2022
Q2 | $912K | Sell |
|
|||||
|
2022
Q1 | $1.29M | Sell |
|
|||||
|
2021
Q4 | $3.95M | Buy |
|
|||||
|
2021
Q3 | $4.59M | Buy |
|
|||||
|
2021
Q2 | $5.1M | Sell |
|
|||||
|
2021
Q1 | $12.7M | Buy |
|